OVID ovidrx.com Company Net Income

Official company branding of Ovid Therapeutics (OVID)

Ovid Therapeutics Inc. (OVID) focuses on developing therapies for patients with severe brain pathologies while mitigating scientific risks. High demand for unique molecules provides the issuer with significant pricing power. The company achieves cost optimization by outsourcing research to proven laboratories. The company's net balance demonstrates profit dynamics, where the metric value of -0.03 captures the current financial result.

OVID: Ovid Therapeutics Inc. Net Profit 07/04/2022 - 11/01/2026

Comprehensive metric breakdowns and analytics for ovidrx.com (OVID)

- stock value and consensus price forecast:
Market Price Ovid Therapeutics|OVID - Price Target Chart
- market capitalization data:
Market Value OVID|OVID - Real Price to Acquire Entire Company
- balance sheet equity data:
Net Assets per Single Share Ovid Therapeutics|OVID - Book Capitalization|Market Capitalization to Book Value ovidrx.com|OVID - Company Total Assets
- debt and solvency information:
Debt to Equity Ratio Ovid Therapeutics Inc.|OVID - Long-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital Ovid Therapeutics|OVID - Company Total Debt|Debt to Book Capital OVID|OVID - Company Long-Term Debts|Company Short-Term Loans and Borrowings Ovid Therapeutics|Immediate Liquidity ovidrx.com
- earnings and valuation multiples information:
OVID - Company Net Income
Summary company analysis:Ovid Rx - OVID
Brand item of Ovid Therapeutics Inc

Selecting high-quality issuers is based on an analysis of operational efficiency through net income trends, which determine the real value of the business. This cash profit for Ovid Therapeutics Inc. (OVID) measures the final financial result net of all expenses, which is critically important for Ovid Therapeutics Inc. (OVID) when monitoring interim payments from partners and progressing through clinical phases, allowing the investor to recognize the risk of capital impairment in a timely manner.

Direct competitors

Company Net Income Biogen Idec (BIIB)|Company Net Income Neurocrine Biosciences|Company Net Income regencellbioscience.com RGC|Net Income AXSM (Axsome Therapeutics, Inc.)|Company Net Income ACAD (ACADIA Pharma)|Net Profit XENE (Xenon Pharmaceuticals Inc)|Net Financial Result Viking Therapeutics Corp (VKTX)|Supernus Pharmaceuticals - Net Profit|CPRX (catalystpharma.com) - Company Profit|DNLI (Denali Therapeutics Inc.) - Net Income|Harmony Biosciences Inc - Final Profit|Net Income BHVN|AMLX (Amylyx Corp) - Profit After Payment of Taxes|Net Profit TRVI|PRAX (praxismedicines.com) - Final Profit|Net Profit AVXL (Anavex Life Sciences Corp.)|CeriBell Inc (CBLL) - Company Net Income|PRTA - Company Net Income|Final Profit ALEC (Alector, Inc.)|ANNX: Net Profit|Omeros (OMER) - Net Profit|Company Net Income Neurogene|AC Immune S.A. - Profit After Tax|Net Profit VYGR|NMRA - Company Net Income|Scilex Holding Company - Net Income|Net Profit tevogen.com TVGN|ACOG: Net Income|cogrx.com - Profit After Payment of Taxes|IKT: Net Profit|SAVA - Net Financial Result|ASRT (Assertio Holdings) - Net Profit|Net Income Coya (COYA)|Company Net Income Vistagen Therapeutics (VTGN)|Net Financial Result Acumen Pharmaceuticals Inc.|CervoMed Inc - Net Income|Final Profit ATHE|Clene Nanomedicine - Net Profit|Net Financial Result PepGen Inc. PEPG|Jupiter Neurosciences Inc (JUNS) - Company Net Income|Company Profit RLMD|ANVS (Annovis Bio Corp) - Net Profit|Net Income Grace Tx (GRCE)|Net Income AIFF (Firefly Neuroscience, Inc)|Net Financial Result anewmeds.com|Company Net Income NeuroSense Therapeutics Ltd. NRSN|Reviva Pharmaceuticals Holdings Inc. (RVPH) - Company Net Income|MTVA: Net Income|NRXS: Company Net Income|HSDT: Net Profit|PASG - Net Financial Result|NEUP (Neuphoria Therapeutics, Inc.) - Net Profit|Company Profit NERV (Minerva Neurosciences Inc)|Company Net Income Athira (ATHA)|Addex - Company Profit|Net Profit ALZN (Alzamend Neuro)|Cyclerion Therapeutics Inc. (CYCN) - Company Net Income|PTIX: Net Income|KTTA - Net Profit|cortigent.com (CRGT) - Company Net Income|Avenue Therapeutics Inc - Final Profit|Company Net Income Brainstorm Cell|Company Net Income caratherapeutics.com CARA|Company Net Income Chromocell Therapeutics Corp. (CHRO)|ELYM - Company Net Income|Intra-Cellular Therapies, Inc. - Net Income|Longboard - Company Net Income|Marinus Pharmaceuticals - Net Profit|Net Financial Result nkgenbiotech.com NKGN|NRBO: Net Profit|Company Profit SAGE|Net Income SNPX|TRVN: Final Profit|Net Income VIGL (Vigil Neuroscience)|Profit After Payment of Taxes WENA|Net Profit CERE (Cerevel Therapeutics, Inc.)